Back to DE D. E. Shaw & Co., Inc.

JANXJANX
Showing 5 of 11 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in JANUX THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 1.1M shares of JANX (JANUX THERAPEUTICS INC), worth $16.8M as of 2026-Q2. The position was increased (+1014.4% shares). JANX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$16.8M

Current Shares

1.1M

Total Value Change

+$13M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+1014.4%
$16.8M0.0%$15.36
46
2026-Q1
Increased
98,395
+200.8%
$1.4M0.0%$13.44
41
2025-Q4
New
32,707
-
$451,3570.0%$13.83
33
2024-Q4
Exited
0
-100.0%
$00.0%$52.50
0
2024-Q3
Decreased
83,989
-14.1%
$3.8M0.0%$46.25
0

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used